Venous and arterial application of an increased volumetric flow stent and matching balloon
11779478 · 2023-10-10
Inventors
Cpc classification
A61F2/90
HUMAN NECESSITIES
A61F2/958
HUMAN NECESSITIES
A61F2002/9583
HUMAN NECESSITIES
A61F2002/826
HUMAN NECESSITIES
A61F2/82
HUMAN NECESSITIES
International classification
A61F2/82
HUMAN NECESSITIES
A61F2/90
HUMAN NECESSITIES
Abstract
The invention includes an expandable stent having a tubular shape when expanded, the shape including a portion t where the stent radius grows with stent length so that the growth in the portion is constant conductance growth or near-constant conductance growth. The invention includes sheaths that will encase the stent to restrict the growth of the stent to the desired expanded shape. The invention also includes expandable stent balloons that expand the stent to the desired shape configuration with constant or near constant conductance portion. The balloons can include a similar sheath or sleeve to restrict the balloon's growth to the desired shape. The stent radius growth can be piecewise, and is not necessarily 4.sup.th order growth, but can be such that r.sup.n/l is a constant in the portion, where n>4.
Claims
1. An expandable stent of length L comprising a structure having a tubular shape when expanded, where the expanded shape includes a radius r at each length 1 of the stent, such that when expanded, the stent has a portion where the radius r at each length 1 of the stent in the portion grows with l such that r.sup.n/1 is a constant at each l in the portion, where n=4, or where the growth of the radius r with length l in the portion is less that that where r.sup.4/1 is a constant in the portion, where l is measured from a beginning end of the stent, and where the length at the beginning of the stent is either 0 or a nonzero value c.
2. The expandable stent of claim 1 where the portion terminates at an end of the stent.
3. The expandable stent of claim 1 where the portion begins after the beginning end of the stent and ends before a termination end of the stent.
4. The expandable stent of claim 1 where the stent is configured to be self-expanding.
5. The expandable stent of claim 1 where the stent is configured to be balloon expandable.
6. The expandable stent of claim 1 wherein n is a polynomial of degree 4, such that the growth of the stent radius with length in the portion is monotonic.
7. The expandable stent of claim 1 having an initial portion at a beginning of the stent, where r is constant over the initial portion.
8. The expandable stent of claim 1 having a terminating portion beginning after a termination of the portion and ending at the terminating end of the stent where r is constant over the terminating portion.
9. An expandable stent of length L comprising a structure having a tubular shape when expanded, where the expanded shape includes a radius r at each length 1 of the stent, such that when expanded, the stent has a portion where the radius grows with stent length l in the portion so that the growth of r is constant conductance growth in the portion, or near constant conductance growth in the portion.
10. The expandable stent of claim 1 where the portion begins at the beginning end of the stent and the length l at the beginning end of the stent is set to a pre-determined effective length.
11. The expandable stent of claim 1, where the growth of the radius r with length l in the portion, which is less that that where r.sup.4/1 is a constant, includes growth of r with l in the portion such that r.sup.n/l is constant, where n>4.
12. The expandable stent of claim 10, where the predetermined effective length is L.sub.eff.
13. The expandable stent of claim 1 where the length l is defined as, ml+C, where C is a constant and ml is a measured length measured from the beginning end of the stent, where ml=0.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION
(34) Venous system blood flow is normally modeled with Poiseuille law, and hydrodynamic relationships, including the expression between flow, pressure, and resistance. The unitary conduit, or increased flow conduit, or constant conductance flow conduit concept described here and in
(35) Rearranging, and combining the two equations:
Q=ΔP*(π/8)*(r.sup.4/L)*(1/μ).
where L represents the length of the cylinder (stent) (measured from the start of the stent), the last three terms represent the numeric, geometric or growth and viscosity factors respectively. Q, or volumetric fluid flow (m.sup.3/sec) or flow, in the venous system, is generally measured in ml/sec or liters/min. In low pressure areas of the arterial system, these relationships can also be used for modeling flow. For instance, we constructed a “unitary” conduit with an initial diameter of 11.2 mm with an initial section of 1 cm of constant radius and expanding to an end diameter of 17.7 mm at a length of 6 cm. The radius expanded with length l so that r.sup.4/l=(0.56).sup.4. We compared fluid flow through the unitary conduit to a second uniform diameter or non-unitary conduit. A total of 4.5 liters was run through each conduit with a head pressure of 25 mm Hg. The time taken to empty the 4.5 l from the reservoir is shown in Table 1 below.
(36) TABLE-US-00001 TABLE 1 Non-Unitary Uniform Conduit Unitary Conduit Trial Time (seconds) Trial Time (seconds) 1 64 1 43 2 64 2 41 3 66 3 44 4 68 4 45 5 68 5 45 Average Time 66 Average Time 43.6 Average Flowrate 68 mL/sec Average Flowrate 103 mL/sec
Thus, the flow rate for the increased flow or unitary conduit was 103 mL/sec and was 68 mL/sec (averaged) for the non-unitary or uniform conduit (constant diameter). As can be seen, errors in the stent radius can have significant consequences on blood flow.
(37) The flow equations can be simplified further by inserting known values for π and μ (the viscosity of blood). As shown in
(38) In reality, a graft or stent starts in an existing conduit. That implies that the initial conduit combination can be viewed as a single conduit. To determine the “effective length” of that portion of the conduit before the onset of the graft or stent, we have L=(ΔPr.sup.4*π)/(Q*8*μ)=L.sub.EFF. the effective length). Consequently, the combined “conduit” at the beginning of the stent or graft has a length, and the length of the “stent” or graft will never be zero. Use of a 1 cm starting length is arbitrary, but not unreasonable, the measured Q (such as estimated from doppler sonar), and ΔP, within biological systems other than arterial, should be small, so L will not be very large. Hence, using a 1 cm constant diameter starting stent is not unreasonable, as it unlikely changes L significantly. Alternatively, the diameter for a specific length to start R4 growth can be chosen, as well as the stent starting diameter for R4 growth after the specific length; then providing for a smooth transition from the starting radius to the radius at the start of R4 growth (such as a linear transition) can be selected
(39) The preferred constant value will be ri.sup.4/(L) where ri is the starting radius of the unitary section near the beginning of the stent. L, as described above or as used in the examples herein, is set as 1 cm, the actual stent length at the start of the growth section in the examples. If the expanding portion or as used herein, is set as 1 cm. If the expanding portion of the stent starts at length LSO, with radius ri at this length, the constant K will be ri.sup.4/(LSO). If the expansion section starts at the beginning of the stent (here measured length=0), then LSO is a value greater than zero, preferably (L.sub.eff) If the growth section is near the beginning of the stent, then the preferred constant value will be ri.sup.4/(L.sub.eff+LSO) where L.sub.eff is described above, and LSO is the actual length of the stent at the start of the growth.
(40) A conduit extending from the common femoral vein to the inferior vena cava was modeled in
(41) These tables can be used not only for designing “unitary” or constant conductance flow or increased flow stents but also for designing/constructing “unitary” balloons of the same diameter/length proportions, where balloon expansion is not uniform but expands non-uniformly, to approximate the unitary stent to be deployed, to match the balloon with the stent. To accomplish this, the balloon thickness can be varied, and/or the balloon materials can be varied with length. Alternatively, the balloon can be encased in a non-elastic unity shaped sleeve, so that when the balloon is expanded, it is restrained by the sleeve into the desired unitary form. Additionally, a non-uniform expanding balloon, such as a “unitary balloon” can be used for angioplasty without stenting, or for pre-dilatation of a stenosis before deploying a unitary or constant conductance stent 100 such as the stents 100, 101, 102 shown in
(42) When shorter length balloons and stents are used, there should be some provision for overlap if the segment to be treated is longer than the length of a chosen balloon or stent. For instance, a 2.0 cm length stent overlap is shown in the
(43) The R4 geometric scaling factor can be illustrated in the following example: a parent vein receiving two tributaries, each 10 mm in diameter, will need to be only 12 mm in diameter (20% larger than each tributary) to maintain pressure unchanged even though the flow has doubled (
(44) Design and Use of Unitary or Constant Conductance Flow Stent Concept
(45) The unitary or constant conductance flow stent concept is applicable in the venous system, and in some circumstances, the arterial system. The concept is to keep the conductance or flow constant in the stent, or portions of the stent, which can be achieved by maintaining the geometric factor (r.sup.4/L) as a constant K in the growth portion of the stent. All examples used herein will have the stent grow after the first cm of length, with constant radius for that first cm, thus avoiding the ambiguity of examining r.sup.4/L as L.fwdarw.0.
(46) As an example, consider a stent having a diameter of 18 mm (9 mm radius) (a common stent diameter used in the common iliac vein) at the end of a 1 cm length of constant radius, then r.sup.4/L=(1.8/2).sup.4/1=0.6561, the constant K used for the remainder of this stent. Consequently, for a 2 cm long stent, the terminating radius would be (0.6561*2).sup.0.25=1.070 or a diameter of 2.14 mm. A 3 cm long stent would have a terminating radius of (0.6561*3).sup.0.25=1.18, or diameter of 2.36 mm; a 4 cm long stent would have radius of 12.7 mm, or a diameter of 25.4 mm; and for a stent length of 5 cm, the terminating radius would be 13.45 mm, or a diameter of 25.7 mm (an overall increase in cross-sectional area of about 123.3% (1.34/0.9)**2 (the iliac vein has been shown to tolerate as large as 24 mm diameter stent sizes).
(47) As used, the “downstream” end of the constant conductance flow stent is larger. In the venous system, “downstream” is closer to the heart than the upstream end of the stent. This increase in diameter with length will assist to help offset flow reduction in the stent, to prevent stent malfunctions like in-stent restenosis caused by ingrowth of clot/tissue which accumulates and lines the wall of the stent. We have calculated the length necessary for various diameters in stents up to 5 cm length, in Table 2 for typical diameter stents used in the iliac system. The first cm in length is of constant diameter.
(48) TABLE-US-00002 TABLE 2 Stent length 1 cm 2 cm 3 cm 4 cm 5 cm CIV 16 19 21 22.6 23.9 EIV 14 16.6 18.4 19.8 20.9 CFV 12 14.3 15.8 17 17.9 (stent diameter in mm)
As described, for a lengthwise cross section though a stent, the outer envelope preferably creases as a 4.sup.the order polynomial, or r.sup.4 with length. Such an increase is not required but is preferred. Slower growth and slower flows, achieved with r.sup.5/l, r.sup.6/l or r.sup.7/l being constant with length can also provide benefits similar to constant conductance flow. Faster growth, and faster flow, such a linear growth, or growth by x.sup.2 or x.sup.3 or a combination such as a second order polynomial or a third order polynomial can also provide a benefit, as flow is further increased with R1, R2 or R3 growth, which can be useful in areas of the stent where restenosis or growth might accumulate from deposits with slower flow.
Stent Growth with Length
(49) As long as the stent radius grows with length over portions of the stent (preferably consistent growth over each portion and preferably monotonic growth overall in the stent), such increased RN growth e.g., 1<n<4, or n>4, is considered “unitary like” growth or “near constant conductance flow herein, and within the scope of the invention. Flow as used herein is volumetric fluid velocity. Additionally, the stent's outer envelope may linearly increase between fixed stent radii at specific lengths, where those radii represent r.sup.4 or RN growth at those radii/length combinations. Connecting the RN radii with linear radius therebetween approximates RN growth in piecewise steps. Such a stepwise construction is suitable for Z stents, such as the five Z stent 300, 301, 302, 303, 304 stacks shown in
(50) Rn growth over the entire stent or portions thereof, such as 1<n<4 or n>4, are considered to be “unitary-like” or “near constant conductance flow” stents. When r.sup.n/l is constant, n<4 implies faster radial growth and flow than R4 growth and R4 flow, and n>4, implies slower radial growth and slower flow than R4 growth. Each provides increased flow over the standard constant diameter stent. As used herein, flow is volumetric fluid velocity (.sup.m3/s).
(51) Radius growth with length is so that r.sup.n/l remain a constant, in all or a portion of the stent, where n>1, is within the scope of the invention. All segmented stents with segments or portions that are unitary or unitary-like growth, are within the scope of the invention. However, it is preferred that the growth of the stent in each segment or portion increases uniformly up to the ending segment radius. Stent growth overall is preferred to be monotonic growth but is not required.
(52) An expanding or increasing dimeter stent is suitable for all stent types (braided, woven, laser cut mesh, and either self-expanding or balloon expandable) for the venous system. While a 4.sup.th order polynomial increase is preferred for the outer envelope of all or portions of the stent (excluding for instance, constant diameter starting and possibly ending sections). These growth factors, e.g., r.sup.n/L where n<4 will grow faster than a constant conductance flow stent, and hence provide increasing flow rates, which can be a benefit in areas where deposits may accumulate, causing restenosis, Slower growth rates, e.g., where r.sup.n/L is constant, where n>4, such as n=5, 6, or 7 will be beneficial where long length stents or long stent stacks (e.g., multiple overlapping stents) are contemplated. While such growth is slower that r.sup.4 growth and hence the volumetric flows is less than r.sup.4 growth, the added benefit is that the ending radius size will be smaller than that in r.sup.4 growth, and hence is more likely to be acceptable in a biological conduit system, such as a vein or artery. All such r.sup.n growth still provides increased flow over constant diameter stents.
(53) For instance, fabrication of a stent with r.sup.4 growth will yield a gradually expanding tube that will double its radius at 16 cm length. In many applications, this growth is too quick, resulting in an ending radius that is too large for the application. A more practical formulation is to keep r.sup.5/l or even r.sup.6/l or r.sup.7/l or larger, constant over the length of the stent or portions thereof. This will yield longer tube lengths before the radius doubles (Table 3); the conductive performance (volumetric flow) will be less than the constant r.sup.4/l formulation but still better (greater than) than that of a uniform cylinder. The ending diameters for various lengths with initial diameters of, 6, 8, and 10 mm is shown in Table 4.
(54) TABLE-US-00003 TABLE 3 Conduit radius increase with length Length at Variable which R.sub.initial Constant doubles (cm)
(55) TABLE-US-00004 TABLE 4 Initial and end diameter of uniform cylindrical and test conduits Ending Ending Ending Constant Initial Diameter at Diameter at Diameter at Geometric Diameter L = 160 mm L = 310 mm L = 620 mm Factor (mm) (mm) (mm) (mm) r 4 4.00 4.00 4.00 6 6.00 6.00 6.00 8 8.00 8.00 8.00 10 10.00 10.00 10.00
(56) To demonstrate performance of slower growth stents, the following experiment was done:
(57) Fabrication of Experimental Conduits
(58) To test less aggressive growth stent designs, r.sup.n growth conduits with n>4 were designed using engineering software (Autodesk, Inc.; San Rafael, CA) and fabricated in a commercial 3D printer (Stratasys; Eden Prairie, MN).
(59) Experimental Test Model
(60) The basic flow model consisted is of a header tank 10 with outflow controlled by a calibrated ball valve 20 (
(61) Results
(62) The flow rates of expanding caliber conduits (r.sup.4-6) compared to traditional constant radius cylindrical conduits are shown in Table 5 and
(63) TABLE-US-00005 TABLE 5 Mean conduit flow rate when R, R.sup.4/L, R.sup.5/L, and R.sup.6/L are held constant (no air-trap) Constant Constant R.sup.4/L Constant R.sup.5/L Constant R.sup.6/L Conduit Initial Radius Flow (cc/min) Flow (cc/min) Flow (cc/min) Length Radius Flow (% (% (% (mm) (mm) (cc/min) improvement) improvement) improvement) Input Pressure = 10 mmHg 160 2 71 188 (+165%***) — — 3 251 349 (+39%***) — — 4 368 435 (+18%**) — — 5 458 492 (+7%) — — 310 2 81 294 (+263%***) 216 (+167%***) 247 (+205%***) 3 294 406 (+38%***) 321 (+9%) 308 (+5%) 4 373 411 (+10%) 387 (+4%) 369 (−1%) 5 428 489 (+14%*) 428 (0%) 383 (−11%) 620 2 26 166 (+538%***) 154 (+492%***) 129 (+396%***) 3 122 253 (+107%***) 249 (+104%***) 240 (+97%***) 4 149 310 (+108%***) 275 (+85%***) 256 (+72%***) 5 240 352 (+47%***) 327 (+36%**) 320 (+33%**) Input Pressure = 25 mmHg 160 2 169 398 (+136%***) — — 3 478 628 (+31%***) — — 4 513 636 (+24%***) — — 5 550 637 (+16%***) — — 310 2 157 427 (+172%***) 301 (+92%***) 285 (+82%***) 3 401 512 (+28%***) 377 (−6%) 386 (−4%) 4 475 575 (+21%***) 447 (−6%) 487 (+3%) 5 549 662 (+21%**) 491 (−11%*) 520 (−5%) 620 2 68 451 (+563%***) 364 (+435%***) 301 (+343%***) 3 267 520 (+95%***) 476 (+78%***) 433 (+62%***) 4 403 551 (+37%***) 504 (+25%***) 509 (+26%***) 5 503 632 (+26%**) 592 (+18%***) 522 (+4%) *P < 0.05 vs. constant radius flow **P < 0.01 vs. constant radius flow ***P < 0.001 vs. constant radius flow
(64) TABLE-US-00006 TABLE 6 Mean conduit flow rate with and without Penrose air-trap (conduit length = 310 mm) Constant Constant Constant Constant R.sup.4/L + Constant R.sup.5/L + Constant R.sup.6/L + Initial Constant R R.sup.4/L air-trap R.sup.5/L air-trap R.sup.6/L air-trap Radius Flow.sup.a Flow Flow Flow Flow Flow Flow (mm) (cc/min) (cc/min, %) (cc/min, %) (cc/min, %) (cc/min, %) (cc/min, %) (cc/min, %) Input Pressure = 10 mmHg 3 294 406 (+38%***) 456 (+55%***) 321 (+9%) 424 (+44%***) 308 (+5%) 376 28%**) 4 373 411 (+10%) 450 (+21%***) 387 (+4%) 444 (+19%***) 369 (−1%) 389 (+4%) 5 428 489 (+14%*) 500 (+17%*) 428 (0%) 467 (+9%*) 383 (−11%) 443 (+4%) Input Pressure = 25 mmHg 3 401 512 (+28%***) 570 (+42%***) 377 (−6%) 553 (+38%***) 386 (−4%) 449 (+12%*) 4 475 575 (+21%***) 602 (+27%**) 447 (−6%) 566 (+19%**) 487 (+3%) 505 (+6%) 5 549 662 (+21%**) 638 (+16%**) 491 (−11%*) 602 (+10%**) 520 (−5%) 553 (+1%) *P < 0.05 vs. constant radius flow **P < 0.01 vs. constant radius flow ***P < 0.001 vs. constant radius flow .sup.aFlow separation did not occur in the constant radius conduits; Penrose air-traps did not affect these flows.
(65) Discussion
(66) Accretive manufacturing (3-D printing) makes it much easier to fabricate expanding caliber stents for biological use. 3D printing with Nitinol is possible for stents, but traditional stent manufacturing techniques could also be used for these expanding stents.
(67) There is a practical limit to the length of the stent depending upon location and use. Examination of Table 3 (length of conduit when initial radius doubles) and Table 5 (measured flow rated for the conduits tested without an air trap) suggests that up to ≈16 cm is practical for stent designs keeping r.sup.4/L constant. As shown in Table 7, for common iliac vein stents of 14 mm diameter, the ending radius is calculated for various length conduits for different r.sup.N N=4, 5, or 6. with all conduits having an initial starting length (1 cm) of constant radius. As shown, combinations up to 64 cm length appear practical for stents keeping r.sup.5/L constant. Longer lengths may be required for particular applications and are possible keeping r.sup.6/L or r.sup.7/L or higher r values constant. Fabrication techniques described above or known to those of ordinary skill in the art may be used to construct the rN expanding sent/conduit.
(68) TABLE-US-00007 TABLE 7 Expanding stent caliber configuration for Iliac vein (Initial Diameter = 14 mm) Constant Constant Constant R.sup.4/L R.sup.5/L R.sup.6/L Length Radius Radius Radius (cm) (mm) (mm) (mm) 0 14.00 14.00 14.00 1 14.00 14.00 14.00 2 16.65 16.08 15.71 3 18.43 17.44 16.81 4 19.80 18.47 17.64 5 20.93 19.32 18.31 6 21.91 20.03 18.87 7 22.77 20.66 19.36 8 23.55 21.22 19.80 9 24.25 21.73 20.19 10 24.90 22.19 20.55 11 25.50 22.62 20.88 12 26.06 23.01 21.18 13 26.58 23.38 21.47 14 27.08 23.73 21.73 15 27.55 24.06 21.99
The expanding caliber stents may have an advantage over the traditional cylindrical prosthetics in the following areas of vascular surgery.
Venous Stents
(69) Venous caliber naturally scales up as tributaries coalesce. The iliac veins are the most common site for stent placement. Common femoral vein is 12 mm in diameter. The external iliac vein is ≈14 mm in diameter; the common iliac vein is slightly larger at ≈16 mm diameter. A gradual configuration as shown in Table 7 starting at 14 mm diameter may provide greater flow than current cylindrical designs. In-stent restenosis is a substantial problem in iliac vein stents and correlates with low inflow. It is believed that the expanding stent will ameliorate these problems of legacy design. The most frequent cause of stent thrombosis is poor inflow; outflow problems are less frequent causes. In either case, the pressure gradient (ΔP) is reduced causing flow decrease. A greater flow rate may be possible with the reduced gradient if the expanded configuration stent is used. Hence, a stent stack can be designed starting at 12 cm diameter in the common femoral, growing at RN until it reaches 14 mm diameter at the external iliac, then growing at RM until it reaches 16 mm diameter at the common iliac and then growing, for instance, at R4 to the end of the stack. Her N and M can be solved for given the respective lengths in each vein segment to be stented. Alternatively, a single RN growth can be chosen, to best fit the circumstances.
(70) Sleeved Stents
(71) These composite stent/sleeved or grafts are used in specific anatomic locations where the prosthetic is subject to external compression/stress. Flow characteristics of the expanded configuration may function better where both the stent and graft (a non-elastic sleeve on the exterior of the sent) expands equally. Indeed, the stent expansion may be greater, but the sleeve will control/limit the expansion of the stent.
(72) As will be understood by one of skill in the art, the length l used in (r=k.sup.n√l), is measured from the start of the conduit, not the start of the expanding section) for standalone stents. Long “stents” can be constructed in steps or segments, by overlapping adjacent stents (such as 2 cm) to create longer stent stacks that emulates a single long stent. Overlapping stent diameters preferably match, by choosing the overlapped segment starting diameters to match, and selecting the geometric expansion of growth factor to match. However, as the stack of stents is used to emulate a single stent, the length used in RN growth is measured from the beginning of the first stent in the stack.
(73) Stents (r=K.sup.n√l where n≥4) can have endless applications where the flow rate through the application is an important factor to the functioning of the system, including the arterial system. Stents are also used to correct intimal hyperplasia at the venous end of dialysis grafts and fistulas. An expanding caliber stent may function better in these locations. In biological systems, use of expanding radii stents should greatly reduce restenosis in these stents.
(74) Stent Designs
(75) In one embodiment, for a stent of selected length L1, the upstream and downstream terminating diameters are chosen (for instance, the upstream diameter can be selected as the standard or minimal diameter for the particular vein segment and choosing the downstream diameter to match the desired geometric factor constant, e.g., r.sup.4/l, or r.sup.n/l for n<4 for faster growth and flows, or r.sup.n/l for n.4 for slower growth and slower flow rates then a constant conductance flow design. Alternatively, the starting and ending diameters can be chosen and then solve for the best fitting value of n in r.sup.n/l, over the selected length L1. Note that n does not have to be an integer value, and n can represent at polynomial of the chosen degree e.g., 4.sup.th order, 5.sup.th order polynomial, etc.
(76) The stents described are for a vein or artery segment that is substantially uniform in diameter absent a stenosis. If the vein or artery segment to be stented, normally has a natural increase in size, that natural increase may be accounted for in the designed “unitary” or increased flow stent, or near constant conductance flow stents, for instance, by increasing the selected stent terminating diameter by adding an additional amount equal to the natural increase in vein size, to get a “unitary plus” sized stent, by selecting the best RN growth to get the chosen diameter.
(77) Stents up to 15 cm long are being produced using constant diameter stents in standard dimensions. These current stents are usually of fixed unchanging diameter. However, there are stents manufactured as expanding tapered stents, See U.S. Pat. Nos. 9,655,710; 8,623,070; 7,637,939, typically chosen to fit an expanding biological conduit. The unitary or constant conductance flow stent concept can be used even in long stents, such as 15 or even 20 cm in length, such as for use in the iliac vein. Such long stents may jail the hypogastric vein, which is well tolerated. However, for long stents, the elasticity of the vein wall can be a limiting factor, and a growth factor for slower growth than the 4.sup.th power for the radius per cm length may be more practical and desirable, such as 5.sup.th, 6.sup.th or 7.sup.th power in r.
(78) Additionally, the invention includes stents that have a portion that is increased volumetric flow such as constant conductance or near constant conductance flow. Consider a stent that has an initial radius r1 of 15 mm or 1.5 cm) and remains constant for two cm. For the next 5 cm, the stent is unitary, with the starting radius of 1.5 cm. In other words, for the next 5 cm, r.sup.4/L remains constant, where L is the distance from the starting point of the stent to the expanding section start, and at the 7.sup.th cm of the stent, L=7 cm). at the end of the growth portion. the stent may continue with a fixed radius or alternatively, the radius in the final portion may further increase with a different RN factor or remain constant or even decrease (not preferred). For instance, at the end of the unitary portion described above, the stent may continue for another 2 cm but over that 2 cm, the radius may smoothly decline, such as linearly (e.g., a first order polynomial), to end at the normal radius of the resident vein, and thus allow for a smooth flow transition from the end of the unitary portion to the end of the stent back into the vein. One design factor is to have the end of the stent designed so that the flow at the end is at least as large as that in terminating vein location.
(79) Slower growth rates than a constant conductance flow stent (e.g., r.sup.n/l is constant) but where n>4, can be used in long stents with lesser impact on vein walls but still providing the benefit of greater flows then provided by a constant diameter stent. Note the growth exponent n does not have to be an integer and can be a polynomial.
(80) The stents and balloons described herein may include radio markers to allow the balloons or stents to be visualized during placement for proper positioning.
(81) The invention includes unitary or constant conductance balloons or near constant conductance balloons, where the radius of the balloon expands with length to match the growth of the stent. For instance, by varying balloon materials or by use of a balloon sleeve that assumes the desired expanded shape. If the stent is a piece-wise growth described above, the balloon should match the growth. The balloon can be constructed of differing materials to provide such varying expansion, or the balloon can also be sleeved to control its growth into the desired shape, by having the sleeve take on the desired expanded shape.
(82) As described, the unitary or near unitary stent can be designed to fit the vein or arterial restrictions and provide increased flows. The stents are preferable to monotonic growth, but there are instances where the growth can decrease. For instance, if a stent bifurcates into two, the two stents will have smaller diameters than the parent, and the bifurcated stents can grow with constant or near constant conductance flow; in these instances, the length in the bifurcated stent can start at the bifurcation.
(83) Measurement of L in a Growth Section
(84) As described, it is preferred that in a growth section where R.sup.N/L is constant, that L is measured from the beginning of the stent system. If you measure the length from the start of the growth stent, then the growth in this case is not identical to that when length is measured from the start of the system. This occurs because r=.sup.n√(Kl) in the growth section. The radius is smaller in a growth section when L is measured from the start of the stent system. Note also that the growth constant K is a different value in the two systems, as K=(rs).sup.n/Ls, where rs is the radius at the start of the growth section, and Ls is the stent length at the start of the growth section.
(85) As an example, consider a two stent system, each 10 cm length, with a 1 cm overlap, where the first conduit is constant, radius of 2 cm, the second conduit grows at R4 after the 1 cm overlap. L=0 at beginning of system L=0 at start of growth conduit K=2.sup.4/10=1.6 K=2.sup.4/1=16 length at end of second stent=19 length at end of second stent=10 (radius at L=19)=.sup.4√{square root over (KL)}=.sup.4√{square root over (1.6*19)}=2.34 (radius at L=10))=.sup.4√{square root over (KL)}=.sup.4=√{square root over (16*10)}=3.55
Clearly, the two measurements of L result in a different growth profile. Measuring L in a growth section from the start of the stent in a growth section is more manufacturer friendly. Otherwise, the manufacturer will have to custom build each stent, with an understanding of the length of the stent system prior to the stent in question. Measuring L from the start of the stent system more closely emulates a single stent particularly in performance.
(86) You can build a stent system using growth stents sections where the growth is referenced from the start of the growth stent. Such a stent system will have different growth profile and different performance characteristics than one where length L is measured from the system start. Care should be taken understanding length measurement which system was used.